Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

AcouSort

3.40 SEK-5.03 %21/10 17:29
Less than 1K followers

ACOU

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-5.03 %
+14.09 %
-5.29 %
+7.26 %
+20.14 %
+15.25 %
-83.42 %
-85.41 %
-56.91 %

AcouSort operates in the medical technology sector. The company has a developed platform technology focused on acoustophoresis, which uses ultrasound to separate and analyze the compositions of biological cells. The technology is mainly used in the analysis of cancer cases and sepsis (blood poisoning). A large part of the research is carried out in collaboration with other players in Life Science. The company was established in 2010 and has its headquarters in Lund.

Read more
Market cap
71.96M SEK
Turnover
17.85K SEK
Revenue
6.85M
EBIT %
-159.39 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
22/10
2026

Extraordinary general meeting '26

25/11
2026

Interim report Q3'26

24/2
2027

Annual report '26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-10-02 16:34

Redeye: AcouSort: OEM and marketing agreements with Calyrex and Intelmetis, plus SEK15m convertible financing

AcouSort
Regulatory press release2026-10-02 15:23

KALLELSE TILL EXTRA BOLAGSSTÄMMA I ACOUSORT AB (PUBL)

AcouSort
Regulatory press release2026-10-02 15:23

NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACOUSORT AB (PUBL)

AcouSort

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-10-01 22:05

AcouSort AB ingår strategiskt OEM-leveransavtal med Calyrex Biosystems Inc. och marknadsföringsavtal med Intelmetis Inc. i kombination med en konvertibelemission om 15 MSEK

AcouSort
Regulatory press release2026-10-01 22:05

AcouSort AB enters into strategic OEM supply agreement with Calyrex Biosystems Inc. and Marketing agreement with Intelmetis Inc. combined with a SEK 15m convertible note financing

AcouSort
Press release2026-08-27 11:59

Redeye: AcouSort (Q2 Review): Largely in line with expectations

AcouSort
Regulatory press release2026-08-26 07:00

AcouSort AB - Halvårsrapport för perioden 1 januari - 30 juni 2026

AcouSort
Regulatory press release2026-08-26 07:00

AcouSort AB - Interim Report for the period January - June 2026

AcouSort
Press release2026-06-29 09:00

AcouSort deltar i viktiga marknadsförings- och partnering-evenemang i Japan

AcouSort
Press release2026-06-29 09:00

AcouSort invited to key marketing and partnering events in Japan

AcouSort
Regulatory press release2026-06-18 09:45

Kommuniké från årsstämma i AcouSort AB

AcouSort
Press release2026-06-03 13:00

AcouSort får order på AcouWash från global ledare inom veterinärdiagnostik

AcouSort
Press release2026-06-03 13:00

AcouSort receives an order for AcouWash from a global leader in veterinary diagnostics

AcouSort
Press release2026-06-01 11:00

AcouSort presenterar och ställer ut på CYTO-konferensen i West Palm Beach i juni

AcouSort
Press release2026-06-01 11:00

AcouSort to present and exhibit at the CYTO conference in West Palm Beach in June

AcouSort
Press release2026-05-28 18:37

Redeye: AcouSort (Q1 Review): Reduced financing concerns and further validation points

AcouSort
Regulatory press release2026-05-27 07:00

AcouSort AB - Delårsrapport för perioden 1 januari - 31 mars 2026

AcouSort
Regulatory press release2026-05-27 07:00

AcouSort AB - Interim Report for the period January - March 2026

AcouSort
Regulatory press release2026-05-20 14:30

AcouSort AB - Årsredovisning 2025

AcouSort
Regulatory press release2026-05-20 14:30

AcouSort AB - Annual report 2025

AcouSort